Login / Signup

Cost-effective In vivo and In vitro Mouse Models for Evaluating Anti-Cryptosporidial Drug Efficacy: Assessing Vorinostat, Docetaxel and Baicalein.

Mingxiao LiuDi ZhangDongqiang WangXiaodong WuYing ZhangJigang YinGuan Zhu
Published in: The Journal of infectious diseases (2023)
Novel in vivo and in vitro models have been developed for cost-effective anti-cryptosporidial drug testing. Vorinostat, docetaxel, and baicalein show potential for repurposing and/or optimization for developing new anti-cryptosporidial drugs.
Keyphrases
  • mouse model
  • locally advanced
  • drug induced
  • adverse drug
  • squamous cell carcinoma
  • risk assessment
  • climate change
  • human health